NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
Showing 1-7 of 7 articles
Coronary interventions
Periprocedural stent thrombosis after percutaneous coronary intervention for a bifurcation lipid-rich plaque August 6, 2021 | 10.4244/EIJ-D-20-00731
Coronary interventions
Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition June 8, 2021 | 10.4244/EIJ-D-21-00181
Coronary interventions
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores August 28, 2020 | 10.4244/EIJ-D-20-00052
Interventions for valvular disease
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry February 7, 2020 | 10.4244/EIJ-D-19-00797
Interventions for valvular disease
Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access October 19, 2018 | 10.4244/EIJ-D-18-00553
Current state of alternative access for transcatheter aortic valve implantation
September 7, 2018 | 10.4244/EIJ-D-18-00552
Interventions for valvular disease
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation April 7, 2017 | 10.4244/EIJ-D-16-00790